GSK advances mRNA flu shot after Phase II success
Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III…
Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?
Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?
Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
GSK’s mRNA Flu Vaccine Heads to Phase III
A new generation of influenza vaccines may be taking shape. GSK announced on Sept. 1, 2026, that it…